Literature DB >> 16953386

Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge.

Ngoc Khoi Nguyen1, Martin E Keck, Alfred Hetzenauer, Christoph K Thoeringer, Wolfgang Wurst, Jan M Deussing, Florian Holsboer, Marianne B Müller, Nicolas Singewald.   

Abstract

RATIONALE: Regional-specific corticotropin-releasing factor receptor 1 (CRF-R1) knockout mice have been generated recently as a tool to dissociate CNS functions modulated by this receptor. In these mice, CRF-R1 function is postnatally inactivated in the anterior forebrain including limbic brain structures but not in the pituitary leading to normal activity of the hypothalamic-pituitary-adrenocortical (HPA) axis under basal conditions and reduced anxiety-related behavior in the light-dark box and the elevated plus maze (EPM) as compared to wild-type (WT) mice (Müller et al., Nat Neurosci 6:1100-1107, 2003).
OBJECTIVE: To identify neurobiological correlates underlying this reduced anxiety-like behavior, the expression of c-Fos, an established marker for neuronal activation, which was examined in response to a mild anxiogenic challenge.
MATERIALS AND METHODS: Mice were placed for 10 min on the open arm (OA) of the EPM, and regional c-Fos expression was investigated by immunohistochemistry.
RESULTS: OA exposure enhanced c-Fos expression in both conditional CRF-R1 knockout and WT mice in a number of brain areas (39 of 55 quantified), including cortical, limbic, thalamic, hypothalamic, and hindbrain regions. The c-Fos response in conditional CRF-R1 knockout animals was reduced in a restricted subset of activated neurons (4 out of 39 regions) located in the medial amygdala, ventral lateral septum, prelimbic cortex, and dorsomedial hypothalamus.
CONCLUSIONS: These results underline the importance of limbic CRF-R1 in modulating anxiety-related behavior and suggest that reduced neuronal activation in the identified limbic and hypothalamic key structures of the anxiety circuitry may mediate or contribute to the anxiolytic-like phenotype observed in mice with region-specific deletion of forebrain CRF-R1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953386     DOI: 10.1007/s00213-006-0513-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  62 in total

1.  Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.

Authors:  G Liebsch; R Landgraf; M Engelmann; P Lörscher; F Holsboer
Journal:  J Psychiatr Res       Date:  1999 Mar-Apr       Impact factor: 4.791

Review 2.  Corticosteroids in relation to fear, anxiety and psychopathology.

Authors:  S M Korte
Journal:  Neurosci Biobehav Rev       Date:  2001-03       Impact factor: 8.989

Review 3.  Neurobiology of emotion perception I: The neural basis of normal emotion perception.

Authors:  Mary L Phillips; Wayne C Drevets; Scott L Rauch; Richard Lane
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

4.  Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas.

Authors:  Damián Refojo; Carlos Echenique; Marianne B Müller; Johannes M H M Reul; Jan M Deussing; Wolfgang Wurst; Inge Sillaber; Marcelo Paez-Pereda; Florian Holsboer; Eduardo Arzt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

5.  Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat.

Authors:  A L Jinks; I S McGregor
Journal:  Brain Res       Date:  1997-10-24       Impact factor: 3.252

6.  Age-related changes in c-fos mRNA induction after open-field exposure in the rat brain.

Authors:  A H Nagahara; R J Handa
Journal:  Neurobiol Aging       Date:  1997 Jan-Feb       Impact factor: 4.673

7.  Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

Authors:  G Griebel; G Perrault; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1998-07       Impact factor: 4.530

8.  Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.

Authors:  G W Smith; J M Aubry; F Dellu; A Contarino; L M Bilezikjian; L H Gold; R Chen; Y Marchuk; C Hauser; C A Bentley; P E Sawchenko; G F Koob; W Vale; K F Lee
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

9.  Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats.

Authors:  Nicolas Salomé; Peter Salchner; Odile Viltart; Henrique Sequeira; Alexandra Wigger; Rainer Landgraf; Nicolas Singewald
Journal:  Biol Psychiatry       Date:  2004-04-01       Impact factor: 13.382

10.  Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress.

Authors:  T Imaki; T Shibasaki; X Q Wang; H Demura
Journal:  Neuroendocrinology       Date:  1995-04       Impact factor: 4.914

View more
  8 in total

1.  Acute hypernatremia exerts an inhibitory oxytocinergic tone that is associated with anxiolytic mood in male rats.

Authors:  Charles J Frazier; Dipanwita Pati; Helmut Hiller; Dan Nguyen; Lei Wang; Justin A Smith; Kaley MacFadyen; Annette D de Kloet; Eric G Krause
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

2.  Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affect.

Authors:  Joanna Dabrowska; Rimi Hazra; Todd H Ahern; Ji-Dong Guo; Alexander J McDonald; Franco Mascagni; Jay F Muller; Larry J Young; Donald G Rainnie
Journal:  Psychoneuroendocrinology       Date:  2011-04-09       Impact factor: 4.905

3.  Regulation of neuronal activation by Alpha2A adrenergic receptor agonist.

Authors:  Valentina L Savchenko; John D Boughter
Journal:  Neurotox Res       Date:  2010-12-30       Impact factor: 3.911

4.  Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice.

Authors:  Ngoc Khoi Nguyen; Simone B Sartori; Herbert Herzog; Ramon Tasan; Günther Sperk; Nicolas Singewald
Journal:  Synapse       Date:  2009-03       Impact factor: 2.562

5.  Identification of brain target neurons using a fluorescent conjugate of corticotropin-releasing factor.

Authors:  Catherine S Hubbard; E Kurt Dolence; Joel A Shires; James D Rose
Journal:  J Chem Neuroanat       Date:  2009-02-07       Impact factor: 3.052

6.  Differential effects of diazepam and MPEP on habituation and neuro-behavioural processes in inbred mice.

Authors:  Amber R Salomons; Nathaly Espitia Pinzon; Hetty Boleij; Susanne Kirchhoff; Saskia S Arndt; Rebecca E Nordquist; Lothar Lindemann; Georg Jaeschke; Will Spooren; Frauke Ohl
Journal:  Behav Brain Funct       Date:  2012-06-11       Impact factor: 3.759

7.  Behavioral Studies and Genetic Alterations in Corticotropin-Releasing Hormone (CRH) Neurocircuitry: Insights into Human Psychiatric Disorders.

Authors:  Gloria Laryea; Melinda G Arnett; Louis J Muglia
Journal:  Behav Sci (Basel)       Date:  2012-06-21

8.  Inhibition of corticotropin releasing factor expression in the central nucleus of the amygdala attenuates stress-induced behavioral and endocrine responses.

Authors:  Leah B Callahan; Kristi E Tschetter; Patrick J Ronan
Journal:  Front Neurosci       Date:  2013-10-29       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.